Nebracetam
From Wikipedia, the free encyclopedia
| This article does not cite any references or sources. (December 2009) |
| Systematic (IUPAC) name | |
|---|---|
| (RS)-4-(aminomethyl)-1-benzylpyrrolidin-2-one | |
| Clinical data | |
| Pregnancy cat. | ? |
| Legal status | Unscheduled (US) |
| Routes | Oral |
| Identifiers | |
| CAS number | 97205-34-0 |
| ATC code | None |
| PubChem | CID 65926 |
| ChemSpider | 59334 |
| UNII | T30038QI8N |
| Chemical data | |
| Formula | C12H16N2O |
| Mol. mass | 204.268 g/mol |
|
|
|
|
| |
Nebracetam is nootropic drug of the racetam family, and an antidepressant (M1 acetylcholine receptor agonist).[1]
References[edit]
- ^ Satoshi Takeo, Hideki Hayashi, Keiko Miyake, Kaori Takagi, Mina Tadokoro, Norio Takagi, Sayuri Oshikawa (May 1997). [onlinelibrary.wiley.com/doi/10.1038/sj.bjp.0701161/full "Effects of delayed treatment with nebracetam on neurotransmitters in brain regions after microsphere embolism in rats"] Check
|url=scheme (help). British Journal of Pharmacology 121: 477–484.
See also[edit]
|
|
| This drug article relating to the nervous system is a stub. You can help Wikipedia by expanding it. |

